Information date: 3 September 2026 — China’s 2026 action plan for stabilising and optimising foreign investment describes wider service-sector pilots, investment promotion and fair-competition work. A company should not treat the plan as a nationwide licence; it should identify the exact province, activity, ownership rule and implementing authority.
Verified facts and scope
The plan covers market access, investment promotion, service support and implementation. It refers to service-sector opening pilots and an integrated Invest in China information and service platform.
National direction can require provincial, zone or sector implementation. Eligibility, timing, application materials and the authority able to issue a licence may differ from the policy headline.
How the effect reaches operations
A policy signal can improve the case for research without removing entity or licence requirements.
Government-procurement and bidding opportunities still require tender-specific qualifications and evidence.
Choosing a location for an incentive before verifying customers and operations can create stranded fixed costs.
Decision
Advance only when a named local authority confirms the route for the planned activity and ownership structure. Compare two locations on access, customer proximity, talent, data, tax, incentives and exit. Treat discretionary support as upside, not as the base-case cash flow.
Implementation checklist
- Define the activity, revenue model, customer, data flow and foreign ownership before contacting a zone.
- Map national negative-list and sector rules to the proposed province and licence.
- Request written programme documents, responsible authority and application window.
- Model operations with and without incentive support.
- Pilot customer demand before committing irreversible facilities or headcount.
- Record conditions, milestones, clawbacks and the next policy-review date.
Evidence and review
For “China foreign-investment action plan: Convert opening measures into a province-and-license test”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Define the activity, revenue model, customer, data flow and foreign ownership before contacting a zone.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Map national negative-list and sector rules to the proposed province and licence.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Request written programme documents, responsible authority and application window.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Release criterion
The release test for “China foreign-investment action plan: Convert opening measures into a province-and-license test” is not document volume. Each material number needs a date and denominator, each action needs an owner and trigger, and each exception needs an escalation route. When the source, operating step and limit align, minor wording differences do not justify another rewrite. If the conclusion still depends on an unverified assumption, narrow the claim or pause the affected decision until direct evidence is available.
Counter-scenario and ownership
The review must also test the opposite of the expected outcome. If “A policy signal can improve the case for research without removing entity or licence requirements.”, the record should already identify who detects it, who can pause the process, and who communicates with affected people or authorities. Direct, current evidence about the studied product, population or transaction takes priority when it conflicts with a broad market statement. Keep both the approval reason and the rejection reason. Later evidence should reopen only the affected question, not trigger an unsupported rewrite of findings that still hold.
Limits of the conclusion
The action plan is not a company-specific approval and implementation can evolve. Regulated sectors, national security review, merger control, data, land and environmental rules may require separate analysis.
